Suchergebnisse - "Orditura, M"

PubPharm (98)

1

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

2

Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population

in: OncoTargets and Therapy | 2020

von Petrillo A | Tirino G | Zito Marino F | +12

3

Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs

enthalten in: Breast (Edinburgh, Scotland) | 2018

von Orditura, M. | Della Corte, C. | Diana, A. | +15

4

Trabectedin in Ovarian Cancer : is it now a Standard of Care?

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2018

von Ventriglia, J. | Paciolla, I. | Cecere, S. | +8

5

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine : A Propensity Score Analysis

enthalten in: Gastroenterology research and practice | 2018

von Ventriglia, J. | Petrillo, A. | Huerta Alváro, M. | +14

6

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM) : a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Ciardiello, F. | Normanno, N. | Martinelli, E. | +55

7

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial

enthalten in: ESMO open | 2016

von Martinelli, E. | Cardone, C. | Troiani, T. | +55

8

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

enthalten in: Annals of oncology | 2016

von Ciardiello, F. | Normanno, N. | Martinelli, E. | +22

9

Transforming growth factor beta receptor (TGFβR) pathway is involved in ligand independent transactivation of AXL receptor in colorectal cancer (CRC) cell lines

enthalten in: Annals of oncology | 2016

von Franzese, E. | Martini, G. | Cardone, C. | +13

10

Prognostic implications of baseline neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in metastatic gastric cancer (GC) patients

enthalten in: Annals of oncology | 2016

von Petrillo, A. | Laterza, M. | Ventriglia, J. | +8

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]